en

PRODUCT DETAIL

NEXPOVIO 20 mg filmom obalené tablety

Code 7341D
MA number EU/1/21/1537/004
Product Form: tbl flm 32x20 mg (blis.PVC/PCTFE/PVC/Al )
MA Status: Ex - Conditional centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XX Other antineoplastic agents
L01XX66 Selinexor
Shelf life: 60
Container: blister PVC/PCTFE/PVC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 18.07.2022
Validity: 18.07.2027
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 08.08.2022
eu-flag.png sk-flag.png